Stocks and Investing
Stocks and Investing
Mon, May 10, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 7, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ZYME) at Strong Buy with Decreased Target to $55 on, May 7th, 2021
Robert Burns of HC Wainwright & Co., Maintained "Zymeworks Inc." (ZYME) at Strong Buy with Decreased Target from $57 to $55 on, May 7th, 2021.
Robert has made no other calls on ZYME in the last 4 months.
There are 4 other peers that have a rating on ZYME. Out of the 4 peers that are also analyzing ZYME, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $41 on, Thursday, February 25th, 2021
- Yigal Nochomovitz of "Citigroup" Downgraded from Strong Buy to Hold and Increased Target to $53 on, Monday, January 25th, 2021
These are the ratings of the 2 analyists that currently disagree with Robert
- Brad Canino of "Credit Suisse" Initiated at Buy and Held Target at $55 on, Wednesday, March 31st, 2021
- David Novak of "Raymond James" Maintained at Strong Buy with Increased Target to $74 on, Tuesday, January 19th, 2021
Contributing Sources